Figure 1From: High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progressionRBM3 expression in normal prostatic epithelium, prostatic intraepithelial neoplasia and in prostate cancer. Immunohistochemical images of RBM3 expression in (A) normal prostatic epithelium, (B) prostatic intraepithelial neoplasia and invasive prostate cancer, ranging from (C) high, (D) moderate, (E) weak to (F) negative expression.Back to article page